Adachi, Yuta <br/><br/>
Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: a case report.  [electronic resource] 

 -  BMC cancer  Feb 2020 
 - 156 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/s12885-020-6626-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Humans<br/>Imidazoles--administration & dosage<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Mutation<br/>Neoplasm Staging<br/>Off-Label Use--standards<br/>Oximes--administration & dosage<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Pyridones--administration & dosage<br/>Pyrimidinones--administration & dosage<br/>Rhabdomyolysis--chemically induced<br/>Treatment Outcome